Bone Marrow Transplantation - Table of Contents alert Volume 48 Issue 10

TABLE OF CONTENTS Volume 48, Issue 10 (October 2013) In this issue Reviews Original Articles Letters to the Editor Corrigenda Also new AOP Advertisement   The Role of HLA-C in Allogeneic Hematopoietic Cell Transplantation Topic Editors: Effie W. Petersdorf and Antoine Toubert ¦ Submission deadline: 15 Jan 2014 In this Research Topic from Frontiers in Immunology, the functional consequences of HLA-C diversity, its role in T and NK-mediated alloreactions that impact risks of acute and chronic GVHD and relapse after blood, marrow and cord blood transplantation, will be highlighted.  Find out more on how you can contribute to this Research Topic. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Communications is ranked #3 in the Multidisciplinary Sciences with an Impact Factor of 10.015* Your research. Our reach. Together we make an impact.  nature.com/naturecommunications  *2012 Journal Citation Reports® (Thomson Reuters, 2013) Reviews Top Viral-specific adoptive immunotherapy after allo-SCT: the role of multimer-based selection strategies N Ramírez and E Olavarría Bone Marrow Transplant 2013 48: 1265-1270; advance online publication, January 14, 2013; 10.1038/bmt.2012.262 Abstract | Full Text The role of allogeneic haematopoietic progenitor cell transplantation in patients with diffuse large B-cell non-Hodgkin lymphomas (DLBCL) S G Papageorgiou, K Cwynarski and P D Kottaridis Bone Marrow Transplant 2013 48: 1271-1278; advance online publication, January 14, 2013; 10.1038/bmt.2012.266 Abstract | Full Text Original Articles Top STEM CELL PROCUREMENT Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies F Awan, S T Kochuparambil, D E Falconer, A Cumpston, S Leadmon, K Watkins, D DeRemer, A Jillella, M Craig and M Hamadani Bone Marrow Transplant 2013 48: 1279-1284; advance online publication, April 15, 2013; 10.1038/bmt.2013.52 Abstract | Full Text CORD BLOOD STEM CELLS Characteristics of chronic GVHD after cord blood transplantation L F Newell, M E D Flowers, T A Gooley, F Milano, P A Carpenter, P J Martin and C Delaney Bone Marrow Transplant 2013 48: 1285-1290; advance online publication, April 15, 2013; 10.1038/bmt.2013.48 Abstract | Full Text PEDIATRIC TRANSPLANTS Late mortality after hematopoietic SCT for a childhood malignancy T Schechter, J D Pole, D Darmawikarta, J Doyle, M Ali, M Egeler, A Gassas, M S Irwin, M Greenberg and P C Nathan Bone Marrow Transplant 2013 48: 1291-1295; advance online publication, May 13, 2013; 10.1038/bmt.2013.64 Abstract | Full Text ALLOGRAFTING Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS M Robin, R Porcher, L Adès, N Boissel, E Raffoux, A Xhaard, J Larghero, C Gardin, C Himberlin, A Delmer, P Fenaux, H Dombret, G Socié and R Peffault de Latour Bone Marrow Transplant 2013 48: 1296-1301; advance online publication, April 15, 2013; 10.1038/bmt.2013.50 Abstract | Full Text AUTOGRAFTING Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center. A Dispenzieri, K Seenithamby, M Q Lacy, S K Kumar, F K Buadi, S R Hayman, D Dingli, M R Litzow, D A Gastineau, D J Inwards, I N Micallef, S M Ansell, P B Johnston, L F Porrata, M M Patnaik, W J Hogan and M A A Gertz Bone Marrow Transplant 2013 48: 1302-1307; advance online publication, April 22, 2013; 10.1038/bmt.2013.53 Abstract | Full Text MICROBIAL ISSUES Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT J Rahiala, M Koskenvuo, P Norja, M Meriluoto, M Toppinen, A Lahtinen, E Väisänen, M Waris, T Vuorinen, U Saarinen-Pihkala, M Lappalainen, T Allander, O Ruuskanen, K Hedman, M Söderlund-Venermo and K Vettenranta Bone Marrow Transplant 2013 48: 1308-1312; advance online publication, May 20, 2013; 10.1038/bmt.2013.63 Abstract | Full Text CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML S Ito, P Pophali, Wu CO, E K Koklanaris, J Superata, G A Fahle, R Childs, M Battiwalla and A J Barrett Bone Marrow Transplant 2013 48: 1313-1316; advance online publication, April 8, 2013; 10.1038/bmt.2013.49 Abstract | Full Text Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation H Nakasone, M Onizuka, N Suzuki, N Fujii, S Taniguchi, K Kakihana, H Ogawa, K Miyamura, T Eto, H Sakamaki, H Yabe, Y Morishima, K Kato, R Suzuki and T Fukuda Bone Marrow Transplant 2013 48: 1317-1323; advance online publication, August 12, 2013; 10.1038/bmt.2013.116 Abstract | Full Text GRAFT-VERSUS-TUMOR EFFECTS Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT A J Innes, R Beattie, R Sergeant, G Damaj, L Foroni, D Marin, E Kanfer, S Mielke, D Milojkovic, D MacDonald, J Pavlu, A Rahemtulla, I Roberts, D Slade, E Bray, J Goldman, J Apperley, R Szydlo, F Dazzi and K Rezvani Bone Marrow Transplant 2013 48: 1324-1328; advance online publication, May 20, 2013; 10.1038/bmt.2013.69 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation I Sakellari, A Barbouti, G Bamichas, D Mallouri, P Kaloyannidis, S Fragidis, I Batsis, C Apostolou, A Karpouza, E Yannaki, C Smias, K Sombolos and A Anagnostopoulos Bone Marrow Transplant 2013 48: 1329-1334; advance online publication, April 15, 2013; 10.1038/bmt.2013.55 Abstract | Full Text PRE-CLINICAL STUDIES Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model C D Fitzhugh, R P Weitzel, M M Hsieh, O A Phang, C Madison, L Luznik, J D Powell and J F Tisdale Bone Marrow Transplant 2013 48: 1335-1341; advance online publication, April 22, 2013; 10.1038/bmt.2013.60 Abstract | Full Text CLINICAL TRIALS Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study W A Wood, A M Deal, B B Reeve, A P Abernethy, E Basch, S A Mitchell, C Shatten, Y Hie Kim, J Whitley, J S Serody, T Shea and C Battaglini Bone Marrow Transplant 2013 48: 1342-1349; advance online publication, April 15, 2013; 10.1038/bmt.2013.58 Abstract | Full Text QUALITY OF LIFE A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation K M Phillips, H L McGinty, J Cessna, Y Asvat, B Gonzalez, M G Cases, B J Small, P B Jacobsen, J Pidala and H S L Jim Bone Marrow Transplant 2013 48: 1350-1357; advance online publication, May 6, 2013; 10.1038/bmt.2013.61 Abstract | Full Text Letters to the Editor Top First use of myeloid colony-stimulating factors in humans R P Gale and A Vorobiov Bone Marrow Transplant 2013 48: 1358; advance online publication, April 15, 2013; 10.1038/bmt.2013.57 Full Text Prognosis of grade 3–4 acute GVHD continues to be dismal K Jamani, J A Russell, A Daly, D Stewart, L Savoie, P Duggan and J Storek Bone Marrow Transplant 2013 48: 1359-1361; advance online publication, April 22, 2013; 10.1038/bmt.2013.59 Full Text BK-virus prophylaxis: still no answer C Phipps, H Y Ng, P Appan, Y Loh, M Koh, A Y L Ho, J J Lee, Y C Linn, B H Tan, Y T Goh and W Hwang Bone Marrow Transplant 2013 48: 1362-1363; advance online publication, May 6, 2013; 10.1038/bmt.2013.62 Full Text Herpesviruses and oral ulcerations in hematopoietic SCT recipients O S Pankratova, A B Chukhlovin, S N Shiryaev, Y A Eismont, V N Vavilov, L S Zubarovskaya and B V Afanasyev Bone Marrow Transplant 2013 48: 1364-1365; advance online publication, May 20, 2013; 10.1038/bmt.2013.74 Full Text Human parvovirus B19 in pediatric and adult recipients of allogeneic hematopoietic stem cell transplantation L Öhrmalm, I Gustafson, A Lindblom, O Norbeck, J-E Johansson, M Brune, P Ljungman and K Broliden Bone Marrow Transplant 2013 48: 1366-1367; advance online publication, August 12, 2013; 10.1038/bmt.2013.110 Full Text Corrigenda Top Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study P G Medd, A J Peniket, T J Littlewood, R Pearce, J Perry, K E Kirkland, B E Shaw, M N Potter, C F Craddock, D W Milligan, A K Fielding, D I Marks and G Cook for the British Society of Blood and Marrow Transplantation (BSBMT) Bone Marrow Transplant 2013 48: 1368; 10.1038/bmt.2013.119 Full Text Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation H Nakasone, M Onizuka, N Suzuki, N Fujii, S Taniguchi, K Kakihana, H Ogawa, K Miyamura, T Eto, H Sakamaki, H Yabe, Y Morishima, K Kato, R Suzuki and T Fukuda Bone Marrow Transplant 2013 48: 1368; 10.1038/bmt.2013.153 Full Text Advertisement With a new Impact Factor of 5.082* and increased total citations, BJC is the 8th most cited general cancer journal! Thank you to all our authors, readers, editors, and reviewers. Check out these top cited BJC papers:  Guidelines for the welfare and use of animals in cancer research   Circulating microRNAs in plasma of patients with gastric cancers    Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.